title: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
abstract: Recent data suggest that inflammatory bowel disease (IBD) patients do not receive preventive services at the same rate as general medical patients. Patients with IBD often consider their gastroenterologist to be the primary provider of care. To improve the care delivered to IBD patients, health maintenance issues need to be co-managed by both the gastroenterologist and primary care team. Gastroenterologists need to explicitly inform the primary care provider of the unique needs of the IBD patient, especially those on immunomodulators and biologics or being considered for such therapy. In particular, documentation of up to date vaccinations are crucial as IBD patients are often treated with long-term immune-suppressive therapies and may be at increased risk for infections, many of which are preventable with vaccinations. Health maintenance issues addressed in this guideline include identification, safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, melanoma and non-melanoma skin cancer as well as identification of depression and anxiety and smoking cessation. To accomplish these health maintenance goals, coordination between the primary care provider, gastroenterology team and other specialists is necessary.
authors.affiliation: Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
authors.forename: Francis A
authors.initials: FA
authors.lastname: Farraye
authors.affiliation: Division of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
authors.forename: Gil Y
authors.initials: GY
authors.lastname: Melmed
authors.affiliation: Division of Gastroenterology, Hospital of the University of Pennsylvania, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Gary R
authors.initials: GR
authors.lastname: Lichtenstein
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Sunanda V
authors.initials: SV
authors.lastname: Kane
mesh_terms: D001007:Anxiety / Q000175:diagnosis / Q000628:therapy; D002644:Chickenpox / Q000209:etiology / Q000517:prevention & control; D003863:Depression / Q000175:diagnosis / Q000628:therapy; D055088:Early Detection of Cancer; D005260:Female; D006525:Hepatitis, Viral, Human / Q000209:etiology / Q000517:prevention & control; D006562:Herpes Zoster / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007251:Influenza, Human / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008545:Melanoma / Q000175:diagnosis*; D008589:Meningococcal Infections / Q000209:etiology / Q000517:prevention & control; D010024:Osteoporosis / Q000175:diagnosis*; D030361:Papillomavirus Infections / Q000209:etiology / Q000517:prevention & control; D011008:Pneumococcal Infections / Q000209:etiology / Q000517:prevention & control; D011315:Preventive Medicine / Q000379:methods*; D011320:Primary Health Care; D012878:Skin Neoplasms / Q000175:diagnosis*; D016540:Smoking Cessation; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D014612:Vaccines / Q000627:therapeutic use*
chemical_list: D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D014612:Vaccines